Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.

Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustin, G. J., Quinnell, T. G., Johnson, J., Clarke, H., Nelstrop, A. E., Bollag, W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074772/
https://www.ncbi.nlm.nih.gov/pubmed/8912548
_version_ 1782138039661756416
author Rustin, G. J.
Quinnell, T. G.
Johnson, J.
Clarke, H.
Nelstrop, A. E.
Bollag, W.
author_facet Rustin, G. J.
Quinnell, T. G.
Johnson, J.
Clarke, H.
Nelstrop, A. E.
Bollag, W.
author_sort Rustin, G. J.
collection PubMed
description Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and during therapy. There was no evidence based on CA 125 of any responses or significant change in tumour growth rate.
format Text
id pubmed-2074772
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20747722009-09-10 Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer. Rustin, G. J. Quinnell, T. G. Johnson, J. Clarke, H. Nelstrop, A. E. Bollag, W. Br J Cancer Research Article Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and during therapy. There was no evidence based on CA 125 of any responses or significant change in tumour growth rate. Nature Publishing Group 1996-11 /pmc/articles/PMC2074772/ /pubmed/8912548 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Rustin, G. J.
Quinnell, T. G.
Johnson, J.
Clarke, H.
Nelstrop, A. E.
Bollag, W.
Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title_full Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title_fullStr Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title_full_unstemmed Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title_short Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
title_sort trial of isotretinoin and calcitriol monitored by ca 125 in patients with ovarian cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074772/
https://www.ncbi.nlm.nih.gov/pubmed/8912548
work_keys_str_mv AT rustingj trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer
AT quinnelltg trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer
AT johnsonj trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer
AT clarkeh trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer
AT nelstropae trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer
AT bollagw trialofisotretinoinandcalcitriolmonitoredbyca125inpatientswithovariancancer

Ejemplares similares